MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO
MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO
Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership
Toronto, CANADA – (June 15, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform to 9,000 healthcare facilities in the US through its new commercial arrangement with MAGNET GROUP GPO.
